SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Silicon Laboratories Inc. – ‘8-K’ for 4/11/21

On:  Tuesday, 4/13/21, at 4:14pm ET   ·   For:  4/11/21   ·   Accession #:  1104659-21-49760   ·   File #:  0-29823

Previous ‘8-K’:  ‘8-K’ on 3/23/21 for 3/22/21   ·   Next:  ‘8-K’ on / for 4/22/21   ·   Latest:  ‘8-K’ on 2/27/24 for 2/21/24

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/13/21  Silicon Laboratories Inc.         8-K:5       4/11/21   10:182K                                   Toppan Merrill/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     25K 
 6: R1          Cover                                               HTML     46K 
 8: XML         IDEA XML File -- Filing Summary                      XML     11K 
 5: XML         XBRL Instance -- tm2112850d1_8k_htm                  XML     14K 
 7: EXCEL       IDEA Workbook of Financial Reports                  XLSX      6K 
 3: EX-101.LAB  XBRL Labels -- slab-20210411_lab                     XML     96K 
 4: EX-101.PRE  XBRL Presentations -- slab-20210411_pre              XML     64K 
 2: EX-101.SCH  XBRL Schema -- slab-20210411                         XSD     12K 
 9: JSON        XBRL Instance as JSON Data -- MetaLinks               25±    33K 
10: ZIP         XBRL Zipped Folder -- 0001104659-21-049760-xbrl      Zip     11K 


‘8-K’   —   Current Report


This is an HTML Document rendered as filed.  [ Alternative Formats ]



 iX:   C:   C:   C:   C:   C:   C:   C:   C: 
 i 0001038074  i false 0001038074 2021-04-11 2021-04-11 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM  i 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported):  i April 11, 2021

 

 i SILICON LABORATORIES INC.

(Exact Name of Registrant as Specified in Charter)

 

 i Delaware    i 000-29823    i 74-2793174
(State or Other Jurisdiction   (Commission File Number)   (IRS Employer
of Incorporation)       Identification No.)

 

 i 400 West Cesar Chavez,  i Austin,  i TX    i 78701
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s telephone number, including area code: ( i 512)  i 416-8500

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

 i ¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

 i ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

 i ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

 i ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange
on which registered
 i Common Stock, $0.0001 par value    i SLAB    i The NASDAQ Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

 

Emerging growth company  i ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Securities Exchange Act of 1934. ¨

 

 

 

 C: 

 

 

 

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

On April 11, 2021, Silicon Laboratories Inc. (“Silicon Laboratories” or the “Company”) appointed Mark D. Mauldin as chief accounting officer. Mr. Mauldin, age 50, has served as Vice President, Finance since February 2016, and held various other finance and accounting positions since joining Silicon Laboratories in 2004. Mr. Mauldin is a Certified Public Accountant and has a master’s degree in accounting and a bachelor’s degree in business administration from the University of Texas at Austin.

 

In connection with his appointment, Mr. Mauldin’s base salary was increased to $300,989. The terms of any equity award to be granted to Mr. Mauldin in connection with such appointment will be determined by the Compensation Committee and reported in a subsequent Form 8-K amendment.

 

There is no arrangement or understanding between Mr. Mauldin and any other person pursuant to which he was selected as an officer of the Company and there are no family relationships between Mr. Mauldin and any of the Company’s directors or executive officers. There are no transactions to which the Company is a party and in which Mr. Mauldin has a direct or indirect material interest that would be required to be disclosed under Item 404(a) of Regulation S-K.

 

 C: 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

    SILICON LABORATORIES INC.
     
April 13, 2021   /s/ John C. Hollister
Date   John C. Hollister
    Senior Vice President and
Chief Financial Officer
    (Principal Financial Officer)

 

 C: 

 

 

 C: 

Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
Filed on:4/13/21
For Period end:4/11/213,  8-K/A
 List all Filings 
Top
Filing Submission 0001104659-21-049760   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., Mar. 28, 9:15:17.1am ET